Improved Screening Test for Idiopathic Infantile Hypercalcemia Confirms Residual Levels of Serum 24,25‐(OH) 2 D 3 in Affected Patients-Reference-Cited by-同舟云学术

Improved Screening Test for Idiopathic Infantile Hypercalcemia Confirms Residual Levels of Serum 24,25‐(OH) 2 D 3 in Affected Patients

Published:2017-04-21 Issue:7 Volume:32 Page:1589-1596
ISSN:0884-0431
Container-title:Journal of Bone and Mineral Research
language:en
Short-container-title:J Bone Miner Res

Author:

Kaufmann Martin¹,Morse Nicole¹,Molloy Billy Joe²,Cooper Donald P²,Schlingmann Karl Peter³,Molin Arnaud⁴⁵,Kottler Marie Laure⁴⁵,Gallagher J Christopher⁶,Armas Laura⁷,Jones Glenville¹

Affiliation:

1. Department of Biomedical & Molecular SciencesQueen's UniversityKingstonONCanada

2. Health Sciences ResearchWaters CorporationWilmslowUK

3. Department of General PediatricsUniversity Children's HospitalMuensterGermany

4. Department of GeneticsUniversity de Basse‐NormandieCaenFrance

5. National Reference Center for Rare Diseases of Calcium and Phosphorus Metabolism (Le Centre National de Référence des maladies rares du métabolisme du calcium et du phosphore)Caen University HospitalCaenFrance

6. Bone Metabolism Unit, Department of MedicineCreighton University School of MedicineOmahaNEUSA

7. Department of Diabetes, Endocrinology, and MetabolismUniversity of Nebraska Medical CenterOmahaNEUSA

Funder

National Institute of Standards and Technology

Publisher

Wiley

Subject

Orthopedics and Sports Medicine,Endocrinology, Diabetes and Metabolism

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jbmr.3135

Reference25 articles.

1. Mutations inCYP24A1and Idiopathic Infantile Hypercalcemia